These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30471415)

  • 41. Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment.
    Géa LP; da Rosa ED; Panizzutti BS; de Aguiar ÉZ; de Oliveira LF; Ferrari P; Piato A; Gomez R; Colombo R; Rosa AR
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1303-1311. PubMed ID: 32363414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional and Molecular Correlates after Single and Repeated Rat Closed-Head Concussion: Indices of Vulnerability after Brain Injury.
    Mountney A; Boutté AM; Cartagena CM; Flerlage WF; Johnson WD; Rho C; Lu XC; Yarnell A; Marcsisin S; Sousa J; Vuong C; Zottig V; Leung LY; Deng-Bryant Y; Gilsdorf J; Tortella FC; Shear DA
    J Neurotrauma; 2017 Oct; 34(19):2768-2789. PubMed ID: 28326890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
    Greig NH; Lecca D; Hsueh SC; Nogueras-Ortiz C; Kapogiannis D; Tweedie D; Glotfelty EJ; Becker RE; Chiang YH; Hoffer BJ
    CNS Neurosci Ther; 2020 Jun; 26(6):636-649. PubMed ID: 31828969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
    Zhang L; Zhang L; Li Y; Li L; Melchiorsen JU; Rosenkilde M; Hölscher C
    J Parkinsons Dis; 2020; 10(2):523-542. PubMed ID: 31958096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term cognitive impairment without diffuse axonal injury following repetitive mild traumatic brain injury in rats.
    Tadepalli SA; Bali ZK; Bruszt N; Nagy LV; Amrein K; Fazekas B; Büki A; Czeiter E; Hernádi I
    Behav Brain Res; 2020 Jan; 378():112268. PubMed ID: 31580914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GLP-1 receptor agonists for Parkinson's disease.
    Mulvaney CA; Duarte GS; Handley J; Evans DJ; Menon S; Wyse R; Emsley HC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012990. PubMed ID: 32700772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
    Jia Y; Gong N; Li TF; Zhu B; Wang YX
    Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide.
    Robertson CS; Garcia R; Gaddam SS; Grill RJ; Cerami Hand C; Tian TS; Hannay HJ
    J Neurotrauma; 2013 May; 30(9):765-74. PubMed ID: 22827443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
    Gedulin BR; Smith PA; Jodka CM; Chen K; Bhavsar S; Nielsen LL; Parkes DG; Young AA
    Int J Pharm; 2008 May; 356(1-2):231-8. PubMed ID: 18291606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.
    Tweedie D; Rachmany L; Kim DS; Rubovitch V; Lehrmann E; Zhang Y; Becker KG; Perez E; Pick CG; Greig NH
    J Neurosci Methods; 2016 Oct; 272():4-18. PubMed ID: 26868732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
    Perry T; Lahiri DK; Sambamurti K; Chen D; Mattson MP; Egan JM; Greig NH
    J Neurosci Res; 2003 Jun; 72(5):603-12. PubMed ID: 12749025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Repetitive Mild Traumatic Brain Injury on Behavioral and Hippocampal Deficits in a Mouse Model of Chronic Stress.
    Algamal M; Saltiel N; Pearson AJ; Ager B; Burca I; Mouzon B; Diamond DM; Mullan M; Ojo JO; Crawford F
    J Neurotrauma; 2019 Sep; 36(17):2590-2607. PubMed ID: 30963958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury.
    Fujiki M; Kubo T; Kamida T; Sugita K; Hikawa T; Abe T; Ishii K; Kobayashi H
    J Clin Neurosci; 2008 Jul; 15(7):791-6. PubMed ID: 18407501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration.
    Rachmany L; Tweedie D; Rubovitch V; Li Y; Holloway HW; Kim DS; Ratliff WA; Saykally JN; Citron BA; Hoffer BJ; Greig NH; Pick CG
    Sci Rep; 2017 Jun; 7(1):3735. PubMed ID: 28623327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury.
    McAteer KM; Corrigan F; Thornton E; Turner RJ; Vink R
    PLoS One; 2016; 11(8):e0160220. PubMed ID: 27505027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
    Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
    Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease.
    Elabi OF; Davies JS; Lane EL
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.